83 related articles for article (PubMed ID: 34267188)
1. Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway.
Xu L; Zhang X; Xin Y; Ma J; Yang C; Zhang X; Hou G; Dong XC; Sun Z; Xiong X; Cao X
Cell Death Dis; 2021 Jul; 12(7):710. PubMed ID: 34267188
[TBL] [Abstract][Full Text] [Related]
2. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.
Lu Y; Wu D; Wang X; Ward SC; Cederbaum AI
Free Radic Biol Med; 2010 Nov; 49(9):1406-16. PubMed ID: 20692331
[TBL] [Abstract][Full Text] [Related]
3. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
Levin I; Petrasek J; Szabo G
Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
[TBL] [Abstract][Full Text] [Related]
4. The micro-743a-3p-GSTM1 pathway is an endogenous protective mechanism against alcohol-related liver disease in mice.
Xu T; Pan Y; Ding Q; Cao F; Chang K; Qiu J; Zhuge H; Hao L; Wei H; Si C; Dou X; Li S
Cell Mol Biol Lett; 2024 Mar; 29(1):35. PubMed ID: 38475733
[TBL] [Abstract][Full Text] [Related]
5. Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?
Hinds TD; Adeosun SO; Alamodi AA; Stec DE
Med Hypotheses; 2016 Oct; 95():54-57. PubMed ID: 27692168
[TBL] [Abstract][Full Text] [Related]
6. Under peroxisome proliferation acyl-CoA oxidase coordinates with catalase to enhance ethanol metabolism.
Chen X; Denning KL; Mazur A; Lawrence LM; Wang X; Lu Y
Free Radic Biol Med; 2023 Nov; 208():221-228. PubMed ID: 37567517
[TBL] [Abstract][Full Text] [Related]
7. ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress.
Jung YS; Radhakrishnan K; Hammad S; Müller S; Müller J; Noh JR; Kim J; Lee IK; Cho SJ; Kim DK; Kim YH; Lee CH; Dooley S; Choi HS
Redox Biol; 2024 May; 71():103107. PubMed ID: 38479224
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Inactivation of the Type 2 Deiodinase Confers Resistance to Alcoholic Liver Steatosis.
Fonseca TL; Fernandes GW; Bocco BMLC; Keshavarzian A; Jakate S; Donohue TM; Gereben B; Bianco AC
Alcohol Clin Exp Res; 2019 Jul; 43(7):1376-1383. PubMed ID: 30908637
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease.
Hsu MF; Koike S; Chen CS; Najjar SM; Meng TC; Haj FG
Biomed Pharmacother; 2024 Jun; 175():116590. PubMed ID: 38653109
[TBL] [Abstract][Full Text] [Related]
10. Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARα activation and subsequent 4-HNE degradation.
Ding L; Wo L; Du Z; Tang L; Song Z; Dou X
PLoS One; 2017; 12(10):e0186357. PubMed ID: 29020055
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance.
Solanki S; Sanchez K; Ponnusamy V; Kota V; Bell HN; Cho CS; Kowalsky AH; Green M; Lee JH; Shah YM
Gastroenterology; 2023 Mar; 164(3):376-391.e13. PubMed ID: 36410445
[TBL] [Abstract][Full Text] [Related]
12. Vitamin B2 enables regulation of fasting glucose availability.
Masschelin PM; Saha P; Ochsner SA; Cox AR; Kim KH; Felix JB; Sharp R; Li X; Tan L; Park JH; Wang L; Putluri V; Lorenzi PL; Nuotio-Antar AM; Sun Z; Kaipparettu BA; Putluri N; Moore DD; Summers SA; McKenna NJ; Hartig SM
Elife; 2023 Jul; 12():. PubMed ID: 37417957
[TBL] [Abstract][Full Text] [Related]
13. Liver proteomics in progressive alcoholic steatosis.
Fernando H; Wiktorowicz JE; Soman KV; Kaphalia BS; Khan MF; Shakeel Ansari GA
Toxicol Appl Pharmacol; 2013 Feb; 266(3):470-80. PubMed ID: 23200777
[TBL] [Abstract][Full Text] [Related]
14. Ablation of secreted phosphoprotein-1 in hepatocytes increases fatty acid oxidation and ameliorates alcohol-associated liver disease.
Das S; Subramaniyam N; Alén R; Komakula SSB; Song Z; Ge X; Han H; Desert R; Athavale D; Magdaleno F; Chen W; Barahona I; Lantvit D; Guzman G; Nieto N
Alcohol Clin Exp Res (Hoboken); 2024 May; 48(5):781-794. PubMed ID: 38503560
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic and Lipidomic Signature of Skeletal Muscle with Constitutively Active Mechanistic Target of Rapamycin Complex 1.
Maroto R; Graber TG; Romsdahl TB; Kudlicki A; Russell WK; Rasmussen BB
J Nutr; 2023 Dec; 153(12):3397-3405. PubMed ID: 37898335
[TBL] [Abstract][Full Text] [Related]
16. The Study of Yin-Chen-Hao-Tang Preventing and Treating Alcoholic Fatty Liver Disease through PPAR Signaling Pathway Based on Network Pharmacology and RNA-Seq Transcriptomics.
Zhu YW; Li D; Ye TJ; Qiu FJ; Wang XL; Yan XF; Lu YL; Xu W; Li H; Hu XD
Evid Based Complement Alternat Med; 2021; 2021():8917993. PubMed ID: 35003311
[TBL] [Abstract][Full Text] [Related]
17. Hepatic protein tyrosine phosphatase Shp2 disruption mitigates the adverse effects of ethanol in the liver by modulating oxidative stress and ERK signaling.
Hsu MF; LeBleu G; Flores L; Parkhurst A; Nagy LE; Haj FG
Life Sci; 2024 Mar; 340():122451. PubMed ID: 38253311
[TBL] [Abstract][Full Text] [Related]
18. PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2.
Jiang C; Liu J; He S; Xu W; Huang R; Pan W; Li X; Dai X; Guo J; Zhang T; Inuzuka H; Wang P; Asara JM; Xiao J; Wei W
Cell Metab; 2023 Dec; 35(12):2183-2199.e7. PubMed ID: 38006878
[TBL] [Abstract][Full Text] [Related]
19. Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation.
Yang C; Yang Y; Hu X; Tang Q; Zhang J; Zhang P; Lu X; Xu J; Li S; Dong Z; Zhu L; Wang L
Liver Int; 2024 Apr; ():. PubMed ID: 38597373
[TBL] [Abstract][Full Text] [Related]
20. Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish.
Ellis JL; Yin C
J Vis Exp; 2017 May; (123):. PubMed ID: 28570521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
